Latest News Feed

Press Release Nov 13, 2024
CMTA and INC Forge Groundbreaking Alliance to Accelerate Comprehensive Research Across All Charcot-Marie-Tooth Disease Types

  • CMTA strengthens its role as the leading force in comprehensive CMT research, forging a new strategic alliance with the Inherited Neuropathy Consortium (INC)
  • Together, CMTA and INC are driving research to accelerate the path toward effective treatments for every type of CMT
Press Release May 7, 2024
CMTA Appoints Science and Technology Veteran, Patricia Verduin, PhD, to the Board of Directors
Press Release Apr 22, 2024
CMTA Announces Addition of Health Insurance Industry Veteran Wendy Arnone to the Board of Directors
Press Release Mar 25, 2024
CMTA Board Evolution: Welcoming Bernard Coulie and Kevin Marks
Press Release Nov 16, 2023
CMTA Announces Participation in Seed Extension Round for Armatus Bio for Novel CMT1A Gene Therapy

FIRST INVESTMENT FROM CMTA’S NEW VENTURE PHILANTHROPY ARM
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
Press Release Nov 6, 2023
CMTA Appoints Biotech Industry Veteran Suzanne Bruhn, PhD as New CEO
Press Release May 9, 2023
Charcot-Marie-Tooth Association: Sperm Donor With CMT Gene Passes It on to Multiple Families
The Charcot-Marie-Tooth Association Earns a Perfect Rating From Charity Navigator
Press Release Feb 23, 2022
The Charcot-Marie-Tooth Association Earns a Perfect Rating From Charity Navigator

The nonprofit evaluator rated The Charcot-Marie-Tooth Association with a perfect 100 score and is the only CMT-related organization to be given four stars.